Today, biomaterial-based solutions play an important role in clinical applications.
They can be implemented e.g. astissue repair scaffolds or replace elements of damaged body parts. As these biomaterials directly interact with the human body, unforseen adverse reactions can occur.
PANBioRA will develop a tool to better assess a patient-specific immune reaction to biomaterials and thus allow improved clinical outcomes.
The PANBioRA consortium shared two new articles!
PANBioRA project partner Dolmen created a questionnaire to gather feedback on end-user experiences regarding the PANBioRA prototype. Your feedback is very much appreciated!
PANBioRA project partner DCU introduced the project during an exciting outreach presentation for secondary school students on Biomedical Engineering!
T4M - Technology for Medical Devices is being postponed and will take place from 8 to 10 June 2021.
The Scandinavian Society for Biomaterials ScSB 2021 conference will be held as virtual event on 14th June 2021.
In 2021 the 26th Congress of ESB will take place online